Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYWC628 for Refractory Diabetic Foot Ulcers
NCT07096934Phase 2Recruiting
- Sponsor
- FibroBiologics
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CYWC628 in diabetic foot ulcer (DFU), sponsored by FibroBiologics. Started Jun 2026; status: recruiting.
02
Drugs
CYWC628
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07096934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096934.